{{Rsnum
|rsid=3218036
|Gene=CCNE1
|Chromosome=19
|position=29814777
|Orientation=plus
|GMAF=0.174
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CCNE1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 44.6 | 48.2
| HCB | 0.0 | 19.0 | 81.0
| JPT | 0.9 | 14.2 | 85.0
| YRI | 0.7 | 7.5 | 91.8
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 19.0 | 81.0
| CHD | 0.9 | 15.6 | 83.5
| GIH | 1.0 | 38.0 | 61.0
| LWK | 1.8 | 12.7 | 85.5
| MEX | 1.7 | 25.9 | 72.4
| MKK | 0.6 | 12.3 | 87.1
| TSI | 4.9 | 39.2 | 55.9
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=19543528
|Title=Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}